VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,381,060 | +69.9% | 119,000 | +72.0% | 0.01% | +62.5% |
| Q2 2023 | $24,352,172 | -16.5% | 69,200 | -25.3% | 0.01% | -33.3% |
| Q1 2023 | $29,175,482 | +21.1% | 92,600 | +11.0% | 0.01% | +9.1% |
| Q4 2022 | $24,084,252 | -7.4% | 83,400 | -7.1% | 0.01% | 0.0% |
| Q3 2022 | $26,001,000 | -43.3% | 89,800 | -44.8% | 0.01% | -42.1% |
| Q2 2022 | $45,819,000 | – | 162,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 86,000 | $14,617,000 | 0.12% |
| SIMPLEX TRADING, LLC | 572 | $9,721,000 | 0.04% |
| JPMORGAN CHASE & CO | 66,600 | $11,319,000 | 0.00% |
| Allianz Asset Management GmbH | 3,900 | $663,000 | 0.00% |